Another accurate Nobel prize forecast?
Washington - Researchers who discovered stem cells and the appetite hormone leptin, who proposed that dark energy is helping the universe expand, and who developed "gene chips" are named in the 2010 Thomson Reuters predictions to win Nobel Prizes for medicine, physics and chemistry.
Thomson Reuters expert David Pendlebury's forecast is made using the company's Web of Knowledge data on how often a researcher's published papers are used and cited by other scientists.
Every year, at least one of his picks has won a Nobel prize.
"Some people perform outstandingly differently from so-called ordinary researchers," Pendlebury, of Thomson Reuters Healthcare & Science division, said in a telephone interview.
Thomson Reuters is the parent company of Reuters.
"People who win the Nobel prize publish about five times as much as the average scientist and are cited 20 times as often as the average scientist."
Appetite and obesity
For the Nobel prize for Physiology or Medicine - to be announced on October 4 - Pendlebury has chosen three possible teams this year.
They are Douglas Coleman of Jackson Laboratory in Bar Harbour, Maine and Jeffrey Friedman of Rockefeller University in New York, for their work discovering leptin, a hormone linked to appetite and obesity.
Friedman and Coleman won a Lasker award, widely considered to help predict Nobel winners, on Tuesday.
Obese rodents given leptin lose weight, but it turns out humans will disobey its signals and overeat anyway. Nonetheless, the hormone is important for understanding the mechanisms of eating.
Nobels often go to groups of three researchers.
Pendlebury has also picked Ernest McCulloch and James Till of the Ontario Cancer Institute in Toronto, who first discovered stem cells in bone marrow in the early 1960s.
Shinya Yamanaka of Japan's Kyoto University and the Gladstone Institute of Cardiovascular Disease in San Francisco was also mentioned for their 2006 discovery of how to make induced pluripotent stem cells or iPS cells from ordinary skin cells.
"It's hard to imagine that won't eventually win a Nobel prize because it is so fundamentally remarkable," said Dr Jeremy Berg of the National Institute of Health's Institute for General Medical Sciences.
Another possible winner is Ralph Steinman of Rockefeller University in New York, who helped discover the role of dendritic cells, immune cells found in the skin, intestines and nose, that are the first line of defence against some microbes. Stimulating dendritic cells helps makes some vaccines work.
"He is the second most cited person in immunology overall," Pendlebury said.
For the physics prize Pendlebury points to Saul Perlmutter of the University of California Berkeley, Adam Riess of Johns Hopkins University in Baltimore and Brian Schmidt of Australian National University for discoveries about how the universe is expanding and how dark energy might permeate the whole universe and affect this.
The physics prize will be announced on October 5.
He chose Charles Bennett of Nasa and Johns Hopkins University in Maryland and Lyman Page and David Spergel of Princeton University in New Jersey, who have done work with the Wilkinson Microwave Anisotropy Probe or WMAP.
This instrument measures the heat left over from the Big Bang to determine the size, shape and composition of the universe. "They are extremely influential," Pendlebury said.
For the chemistry prize, to be awarded on October 6, Pendlebury favours Patrick Brown of Stanford University School of Medicine in California.
He invented DNA microarrays, also known widely as gene chips, which are broadly used by scientists now to see which genes are active in various cells.
Pendlebury also named Stephen Lippard of the Massachusetts Institute of Technology, who found a way to make platinum disrupt DNA, the basis of a family of cancer drugs that use the metal.
In 2009, Pendlebury correctly predicted that Elizabeth Blackburn, Carol Greider and Jack Szostak would share the Nobel prize for Medicine for discovering telomerase, an enzyme involved in aging.
He considers previous years' picks to also still be in the running.